IP Library Granted Patent US 10,227,621
Granted Patent B2
US 10,227,621 · App. 15/514,321 · Granted Mar 12, 2019

Method for preparing an aqueous acrylamide solution having a low acrylic acid concentration

Inventors: Michael Guenter Braun (Heidelberg, DE); Juergen Daeuwel (Heidelberg, DE); Hans-Juergen Lang (Dudenhofen, DE); Peter Oedman (Neustadt, DE); Kai-Uwe Baldenius (Mannheim, DE); Matthias Kleiner (Goennheim, DE); Michael Kiefer (Boehl-Iggelheim, DE); Stephan Freyer (Neustadt, DE); Michael Budde (Ilvesheim, DE)
Assignee: BASF SE
C12P13/02C07C233/09C08F20/56C08L33/26C09K8/588C12Y402/01084D21H17/375C08L2201/54
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,227,621
App. No.
15/514,321
Granted
Mar 12, 2019
Kind
B2
Abstract

The present invention relates to methods for preparing an aqueous acrylamide solution having a low acrylic acid concentration. In addition, the present invention relates to methods for reducing the acrylic acid concentration of an aqueous acrylamide solution. The methods involve a bioconversion of acrylonitrile to acrylamide in the presence of a biocatalyst, wherein during the bioconversion the content of acrylonitrile is maintained at 0.3 w/w % or more referred to the total weight of the composition in the reactor. Also provided is an aqueous acrylamide solution which is obtained by the methods of the present invention. Furthermore, the present invention is related to an acrylamide homopolymer or copolymer obtained by polymerizing the acrylamide of the aqueous solution.

Claims (90)

1. A method for preparing an aqueous acrylamide solution, the method comprising:

(a) adding acrylonitrile, water, and a biocatalyst capable of converting acrylonitrile to acrylamide to a reactor to obtain a composition for bioconversion;

(b) performing a bioconversion of the acrylonitrile to acrylamide in the reactor; and

(c) adding further acrylonitrile such that a content of acrylonitrile during the bioconversion is maintained at 0.3 w/w % or more, relative to the total weight of the composition in the reactor, for 10 minutes to 48 hours,

wherein the adding of further acrylonitrile comprises:

(i) maintaining an acrylonitrile content in a first range, which is from 1.2 w/w % to 6 w/w % relative to the total weight of the composition in the reactor, for a first period of time, which is from 30 minutes to 4 hours;

(ii) decreasing the acrylonitrile content from the first range to a second range, which is from 0.3 w/w % to 1.2 w/w % relative to the total weight of the composition in the reactor; and

(iii) maintaining an acrylonitrile content in the second range for a second period of time, which is from 30 minutes to 24 hours.

2. The method according to claim 1 , wherein an acrylic acid concentration of the composition at the end of the bioconversion is 1500 ppm or less, relative to the total weight of the composition at the end of the bioconversion.

3. The method of claim 1 , wherein a weight ratio of the biocatalyst, acrylonitrile and water added during the (a) to (c) is 0.001 to 0.5 w/w % of the biocatalyst, 22 to 45 w/w % of acrylonitrile and a balance to 100 w/w % of water, relative to the total weight (100) w/w %) of the combined weights of the biocatalyst, acrylonitrile and water added during the (a) to (c).

4. The method of claim 1 , wherein the bioconversion is performed at a temperature of from 5° C. to 40° C. for 10 minutes to 48 hours.

5. The method of claim 1 , wherein the content of acrylonitrile during the bioconversion is maintained at 6 w/w % or less, relative to the total weight of the composition in the reactor.

6. The method of claim 1 , wherein

the first range is from 1.2 w/w % to 4 w/w % relative to the total weight of the composition in the reactor,

the first period of time is from 30 minutes to 3 hours,

the second range is from 0.5 w/w % to 1.1 w/w % relative to the total weight of the composition in the reactor, and

the second period of time is from 30 minutes to 12 hours.

7. The method of claim 6 , wherein

the first range is from 1.3 w/w % to 3 w/w % relative to the total weight of the composition in the reactor,

the first period of time is from 30 minutes to 2 hours,

the second range is from 0.6 w/w % to 1.0 w/w % relative to the total weight of the composition in the reactor, and

the second period of time is from 1 hour to 8 hours.

8. The method of claim 1 , wherein the method is carried out using a semi-batch process.

9. The method of claim 1 , wherein the content of acrylonitrile is measured using Fourier Transform Infrared Spectroscopy (FTIR).

10. The method of claim 1 , wherein the biocatalyst encodes the enzyme nitrile hydratase.

11. The method of claim 1 , wherein the biocatalyst is at least one selected from the group consisting of Rhodococcus, Aspergillus, Acidovorax, Agrobacterium, Bacillus, Bradyrhizobium, Burkholderia, Escherichia, Geobacillus, Klebsiella, Mesorhizobium, Moraxella, Pantoea, Pseudomonas, Rhizobium, Rhodopseudomonas, Serratia, Amycolatopsis, Arthrobacter, Brevibacterium, Corynebacterium, Microbacterium, Micrococcus, Nocardia, Pseudonocardia, Trichoderma, Myrothecium, Aureobasidium, Candida, Cryptococcus, Debaryomyces, Geotrichum, Hanseniaspora, Kluyveromyces, Pichia, Rhodotorula, Comomonas , and Pyrococcus.

12. The method of claim 11 , wherein the biocatalyst is at least one selected from the group consisting of Rhodococcus, Pseudomonas, Escherichia and Geobacillus.

13. The method of claim 1 , wherein the biocatalyst is at least one selected from the group consisting of Rhodococcus rhodochrous, Rhodococcus pyridinovorans, Rhodococcus erythropolis, Rhodococcus equi, Rhodococcus ruber, Rhodococcus opacus, Aspergillus niger, Acidovorax avenae, Acidovorax facilis, Agrobacterium tumefaciens, Agrobacterium radiobacter, Bacillus subtilis, Bacillus pallidus, Bacillus smithii, Bacillus sp BR449, Bradyrhizobium oligotrophicum, Bradyrhizobium diazoefficiens, Bradyrhizobium japonicum, Burkholderia cenocepacia, Burkholderia gladioli, Escherichia coli, Geobacillus sp, RAPc8, Klebsiella oxytoca, Klebsiella pneumonia, Klebsiella variicola, Mesorhizobium ciceri, Mesorhizobium opportunistum, Mesorhizobium sp F28, Moraxella, Pantoea endophytica, Pantoea agglomerans, Pseudomonas chlororaphis, Pseudomonas putida, Rhizobium, Rhodopseudomonas palustris, Serratia liquefaciens, Serratia marcescens, Amycolatopsis, Arthrobacter, Brevibacterium sp CH1 , Brevibacterium sp CH2, Brevibacterium sp R312, Brevibacterium imperiale, Brevibacterium casei, Corynebacterium nitrilophilus, Corynebacterium pseudodiphteriticum, Corynebacterium glutamicum, Corynebacterium hoffmanii, Microbacterium imperiale, Microbacterium smegmatis, Micrococcus luteus, Nocardia globerula, Nocardia rhodochrous, Nocardia sp 163 , Pseudonocardia thermophila, Trichoderma, Myrothecium verrucaria, Aureobasidium pullulans, Candida famata, Candida guilliermondii, Candida tropicalis, Cryptococcus flavus, Cryptococcus sp UFMG-Y28 , Debaryomyces hanseii, Geotrichum candidum, Geotrichum sp JR1, Hanseniaspora, Kluyveromyces thermotolerans, Pichia kluyveri, Rhodotorula glutinis, Comomonas testosteroni, Pyrococcus abyssi, Pyrococcus furiosus , and Pyrococcus horikoshii.

14. The method of claim 13 , wherein the biocatalyst is Rhodococcus rhodochrous.

15. The method of claim 13 , wherein the biocatalyst is Rhodococcus pyridinovorans.

16. The method of claim 1 , wherein the biocatalyst has been dried before being added to the reactor.

17. The method of claim 16 , wherein the biocatalyst has been dried by freeze-drying, spray drying, heat drying, vacuum drying, fluidized bed drying, spray granulation, or a combination thereof.

18. The method of claim 16 , wherein the dried biocatalyst is added to the reactor.

19. The method of claim 16 , wherein the dried biocatalyst is reconstituted before being added to the reactor.

20. The method of claim 19 , wherein the biocatalyst is reconstituted by suspending in an aqueous composition.

21. A method for preparing an aqueous acrylamide solution, the method comprising:

(a) adding acrylonitrile, water, and a biocatalyst capable of converting acrylonitrile to acrylamide to a reactor to obtain a composition for bioconversion;

(b) performing a bioconversion of the acrylonitrile to acrylamide in the reactor; and

(c) adding further acrylonitrile such that a content of acrylonitrile during the bioconversion is maintained at 0.3 w/w % or more until an acrylamide content reaches at least 20 w/w %, relative to the total weight of the composition in the reactor,

wherein the adding of further acrylonitrile comprises:

(i) maintaining an acrylonitrile content in a first range, which is from 1.2 w/w % to 6 w/w % relative to the total weight of the composition in the reactor, for a first period of time, which is from 30 minutes to 4 hours;

(ii) decreasing the acrylonitrile content from the first range to a second range, which is from 0.3 w/w % to 1.2 w/w % relative to the total weight of the composition in the reactor; and

(iii) maintaining an acrylonitrile content in the second range for a second period of time, which is from 30 minutes to 24 hours.

22. The method of claim 21 , wherein

the first range is from 1.2 w/w % to 4 w/w % relative to the total weight of the composition in the reactor,

the first period of time is from 30 minutes to 3 hours,

the second range is from 0.5 w/w % to 1.1 w/w % relative to the total weight of the composition in the reactor, and

the second period of time is from 30 minutes to 12 hours.

23. The method of claim 22 , wherein

the first range is from 1.3 w/w % to 3 w/w % relative to the total weight of the composition in the reactor,

the first period of time is from 30 minutes to 2 hours,

the second range is from 0.6 w/w % to 1.0 w/w % relative to the total weight of the composition in the reactor, and

the second period of time is from 1 hour to 8 hours.

24. A method for reducing an acrylic acid concentration of an aqueous acrylamide solution prepared by converting acrylonitrile to acrylamide using a biocatalyst, the method comprising:

(a) adding acrylonitrile, water, and a biocatalyst capable of converting acrylonitrile to acrylamide to a reactor to obtain a composition for bioconversion;

(b) performing a bioconversion of the acrylonitrile to acrylamide in the reactor; and

(c) adding further acrylonitrile such that a content of acrylonitrile during the bioconversion is maintained at 0.3 w/w % or more, relative to the total weight of the composition in the reactor,

wherein the adding of further acrylonitrile comprises:

(i) maintaining an acrylonitrile content in a first range, which is from 1.2 w/w % to 6 w/w % relative to the total weight of the composition in the reactor, for a first period of time, which is from 30 minutes to 4 hours;

(ii) decreasing the acrylonitrile content from the first range to a second range, which is from 0.3 w/w % to 1.2 w/w % relative to the total weight of the composition in the reactor; and

(iii) maintaining an acrylonitrile content in the second range for a second period of time, which is from 30 minutes to 24 hours.

25. The method of claim 24 , wherein

the first range is from 1.2 w/w % to 4 w/w % relative to the total weight of the composition in the reactor,

the first period of time is from 30 minutes to 3 hours,

the second range is from 0.5 w/w % to 1.1 w/w % relative to the total weight of the composition in the reactor, and

the second period of time is from 30 minutes to 12 hours.

26. The method of claim 25 , wherein

the first range is from 1.3 w/w % to 3 w/w % relative to the total weight of the composition in the reactor,

the first period of time is from 30 minutes to 2 hours,

the second range is from 0.6 w/w % to 1.0 w/w % relative to the total weight of the composition in the reactor, and

the second period of time is from 1 hour to 8 hours.

27. A method for preparing an aqueous acrylamide solution, comprising:

(a) adding acrylonitrile, water, and a biocatalyst capable of converting acrylonitrile to acrylamide to a reactor to obtain a composition for bioconversion;

(b) performing a bioconversion of the acrylonitrile to acrylamide in the reactor;

(c) adding further acrylonitrile such that a content of acrylonitrile during the bioconversion is maintained at 0.3 w/w % or more, relative to the total weight of the composition in the reactor; and

(d) obtaining a composition at the end of the bioconversion, which has an acrylic acid concentration of 1500 ppm or less, relative to the total weight of the composition at the end of the bioconversion,

wherein the adding of further acrylonitrile comprises:

(i) maintaining an acrylonitrile content in a first range, which is from 1.2 w/w % to 6 w/w % relative to the total weight of the composition in the reactor, for a first period of time, which is from 30 minutes to 4 hours;

(ii) decreasing the acrylonitrile content from the first range to a second range, which is from 0.3 w/w % to 1.2 w/w % relative to the total weight of the composition in the reactor; and

(iii) maintaining an acrylonitrile content in the second range for a second period of time, which is from 30 minutes to 24 hours.

28. The method of claim 27 , wherein

the first range is from 1.2 w/w % to 4 w/w % relative to the total weight of the composition in the reactor,

the first period of time is from 30 minutes to 3 hours,

the second range is from 0.5 w/w % to 1.1 w/w % relative to the total weight of the composition in the reactor, and

the second period of time is from 30 minutes to 12 hours.

29. The method of claim 28 , wherein

the first range is from 1.3 w/w % to 3 w/w % relative to the total weight of the composition in the reactor,

the first period of time is from 30 minutes to 2 hours,

the second range is from 0.6 w/w % to 1.0 w/w % relative to the total weight of the composition in the reactor, and

the second period of time is from 1 hour to 8 hours.

Assignments (13)
SECURITY INTEREST Recorded Nov 14, 2025
From: CHEM-AQUA, INC.; DIVERSEY, INC.; DIVERSEY TASKI, INC.; INNOVATIVE WATER CARE, LLC; NCH CORPORATION; NCH LIFE SCIENCES LLC; SOLENIS TECHNOLOGIES, L.P.
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 073570/0838 →
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2025
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
To: BIRKO CORPORATION; DIVERSEY, INC.; DIVERSEY TASKI, INC.; INNOVATIVE WATER CARE, LLC; SOLENIS TECHNOLOGIES, L.P.
Reel/Frame 073564/0864 →
SECURITY AGREEMENT (NOTES) Recorded Oct 10, 2025
From: DIVERSEY, INC.; DIVERSEY TASKI, INC.; INNOVATIVE WATER CARE, LLC; SOLENIS TECHNOLOGIES, L.P.
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 073061/0885 →
RELEASE OF 2023 NOTES PATENT SECURITY INTERESTS Recorded Oct 10, 2025
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
To: BIRKO CORPORATION; DIVERSEY, INC.; DIVERSEY TASKI, INC.; INNOVATIVE WATER CARE, LLC; SOLENIS TECHNOLOGIES, L.P.
Reel/Frame 073074/0198 →
SECURITY AGREEMENT (2024 NOTES) Recorded Jun 24, 2024
From: BIRKO CORPORATION; DIVERSEY, INC.; DIVERSEY TASKI, INC.; INNOVATIVE WATER CARE, LLC; SOLENIS TECHNOLOGIES, L.P.
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 067824/0278 →
2023 NOTES PATENT SECURITY AGREEMENT Recorded Jul 7, 2023
From: BIRKO CORPORATION; SOLENIS TECHNOLOGIES, L.P.; INNOVATIVE WATER CARE, LLC; DIVERSEY, INC.; DIVERSEY TASKI, INC.; INNOVATIVE WATER CARE GLOBAL CORPORATION
To: BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
Reel/Frame 064225/0170 →
SECURITY AGREEMENT (NOTES) Recorded Sep 14, 2022
From: SOLENIS TECHNOLOGIES, L.P.; INNOVATIVE WATER CARE, LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. AS COLLATERAL AGENT
Reel/Frame 061432/0821 →
NOTES SECURITY AGREEMENT Recorded Nov 10, 2021
From: INNOVATIVE WATER CARE, LLC; SOLENIS TECHNOLOGIES, L.P.
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
Reel/Frame 058103/0066 →
TERM LOAN PATENT SECURITY AGREEMENT Recorded Nov 10, 2021
From: INNOVATIVE WATER CARE, LLC; SOLENIS TECHNOLOGIES, L.P.
To: GOLDMAN SACHS BANK USA
Reel/Frame 058102/0407 →
ABL PATENT SECURITY AGREEMENT Recorded Nov 10, 2021
From: INNOVATIVE WATER CARE, LLC; SOLENIS TECHNOLOGIES, L.P.
To: BANK OF AMERICA, N.A.
Reel/Frame 058102/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2020
From: BASF SE
To: SOLENIS TECHNOLOGIES, L.P.
Reel/Frame 054735/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2019
From: BASF SE
To: SOLENIS TECHNOLOGIES, L.P.
Reel/Frame 048697/0892 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: BRAUN, MICHAEL GUENTER; DAEUWEL, JUERGEN; LANG, HANS-JUERGEN; OEDMAN, PETER; BALDENIUS, KAI-UWE; KLEINER, MATTHIAS; KIEFER, MICHAEL; FREYER, STEPHAN; BUDDE, MICHAEL
To: BASF SE
Reel/Frame 045441/0869 →
Priority Claims (1)
EP 14003377 · Sep 30, 2014 · regional
Continuity (1)
Related Publication 20170283840A1 · Oct 5, 2017
Cited By (1)
US 12,209,364